United Kingdom renal denervation market may flourish with an impressive CAGR during the forecast period of 2023-2027, on the backbone of increasing number of patients suffering from hypertension
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The United Kingdom renal denervation market is segmented by technology, product, therapeutic area, end user, competitional landscape, and regional distribution. Based on technology, the market is further segmented into ultrasound ablation, radiofrequency ablation, pharmacologic ablation, and micro-infusion. Radiofrequency ablation is anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to its advantages like safety of the procedure and time efficiency. Also, ultrasound ablation is expected to register significant growth in the next five years due to the high-frequency sound waves that ablates the nerves without getting in direct contact with the tissues, thus reducing injuries to the renal arteries.
By product, the market is fragmented into catheters, single electrode catheter, multi electrode catheter, RF generator, and others. Catheters are anticipated to lead the market segment and hold the largest revenue shares of the market in the upcoming five years on the grounds of traditional use of the medical devices. RF generators may register fastest growing CAGR in the next five years due to radiofrequency ablation being the most preferred method for the treatment.
Medtronic United Kingdom, Boston Scientific Limited, Abbott Laboratories Limited, CardioSonic Limited, Terumo UK Limited, Johnson & Johnson Limited, among others is a partial list of major market players responsible for the growth of United Kingdom renal denervation market.
Years considered for this report:
Historical Years: 2017-2020Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F
Objective of the Study:
- To analyze the historical growth in the market size of the United Kingdom Renal Denervation market from 2017 to 2021.
- To estimate and forecast the market size of United Kingdom Renal Denervation Market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast the United Kingdom Renal Denervation Market based on Technology, Product, Therapeutic Area, End User, Region, and Company.
- To identify the dominant region or segment in the United Kingdom Renal Denervation Market.
- To identify drivers and challenges for the United Kingdom Renal Denervation Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the United Kingdom Renal Denervation Market.
- To identify and analyze the profiles of leading players operating in the United Kingdom Renal Denervation Market.
- To identify key sustainable strategies adopted by market players inUnited Kingdom Renal Denervation Market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies, which could not be identified due to the limitations of secondary research. The publisher analyzed the companies and presence of all major players across the country.
The publisher calculated the market size of the United Kingdom Renal Denervation Market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.
Key Target Audience:
- Renal Denervation companies
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to renal denervation
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, United Kingdom renal denervation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
United Kingdom Renal Denervation Market, By Technology:
- Ultrasound Ablation
- Radiofrequency Ablation
- Pharmacologic Ablation
- Micro-infusion
United Kingdom Renal Denervation Market, By Product:
- Catheters
- Single Electrode Catheter
- Multi Electrode Catheter
- RF Generator
- Others
United Kingdom Renal Denervation Market, By Therapeutic Area:
- Hypertension
- Heart Failure
- Diabetes
- Renal Failure
- Others
United Kingdom Renal Denervation Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
United Kingdom Renal Denervation Market, By Region:
- London
- East Anglia
- Southwest
- Southeast
- Scotland
- East Midlands
- Yorkshire & Humberside
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United Kingdom renal denervation market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:Company Information
Detailed analysis and profiling of additional market players (up to five).Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic United Kingdom
- Boston Scientific Limited
- Abbott Laboratories Limited
- CardioSonic Limited
- Terumo UK Limited
- Johnson & Johnson Limited